The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Lifestyle drug is an term commonly applied to medications which treat non–life-threatening and non-painful conditions such as baldness, wrinkles, erectile dysfunction, or acne, which the speaker perceives as either not medical problems at all or as minor medical conditions relative to others. Proponents point out that improving the patient's subjective quality of life has always been a primary concern of medicine.
The global Lifestyle Drugs market size is expected to reach US$ 37620 million by 2029, growing at a CAGR of 2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Lifestyle Drugs in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Lifestyle Drugs market. Depression, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dermatology segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Sales Channel. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lifestyle Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lifestyle Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lifestyle Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lifestyle Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lifestyle Drugs covered in this report include Allergan, Eli Lilly, Pfizer, AstraZeneca, Teva, Sun Pharmacetuicals, Merck, Forendo Pharma and Avolynt, etc.
The global Lifestyle Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Allergan
- Eli Lilly
- Pfizer
- AstraZeneca
- Teva
- Sun Pharmacetuicals
- Merck
- Forendo Pharma
- Avolynt
- Alkermes
- Dong-A ST
- Dermira
- Avanir Pharmaceuticals
- Menlo Therapeutics
- Galderma
- Cerecor
- Corcept Therapeutics
- Anterios
- Euthymics Bioscience
- Cosmo Pharmaceuticals
- AndroScience
- Acerus Pharmaceuticals
- Celtaxsys
- Futura Medical Developments
- Follicum
Global Lifestyle Drugs market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lifestyle Drugs market, Segment by Type:
By Therapeutic Type
- Depression
- Dermatology
- Sexual Dysfunction
- Obesity
- Others
By Form
- Tablet
- Gel
- Cream
- Oral Syrups
- Parenteral
- Others
Global Lifestyle Drugs market, by Sales Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Lifestyle Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Lifestyle Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Sales Channel, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Lifestyle Drugs Market Overview
1.1 Lifestyle Drugs Product Overview
1.2 Lifestyle Drugs Market Segment by Type
1.2.1 Depression
1.2.2 Dermatology
1.2.3 Sexual Dysfunction
1.2.4 Obesity
1.2.5 Others
1.3 Global Lifestyle Drugs Market Size by Type
1.3.1 Global Lifestyle Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Lifestyle Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Lifestyle Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Lifestyle Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Lifestyle Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Lifestyle Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Lifestyle Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Lifestyle Drugs Sales Breakdown by Type (2018-2023)
2 Global Lifestyle Drugs Market Competition by Company
2.1 Global Top Players by Lifestyle Drugs Sales (2018-2023)
2.2 Global Top Players by Lifestyle Drugs Revenue (2018-2023)
2.3 Global Top Players by Lifestyle Drugs Price (2018-2023)
2.4 Global Top Manufacturers Lifestyle Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Lifestyle Drugs Market Competitive Situation and Trends
2.5.1 Lifestyle Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Lifestyle Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lifestyle Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Lifestyle Drugs Market
2.8 Key Manufacturers Lifestyle Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Lifestyle Drugs Status and Outlook by Region
3.1 Global Lifestyle Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Lifestyle Drugs Historic Market Size by Region
3.2.1 Global Lifestyle Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Lifestyle Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Lifestyle Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Lifestyle Drugs Forecasted Market Size by Region
3.3.1 Global Lifestyle Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Lifestyle Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Lifestyle Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Lifestyle Drugs by Sales Channel
4.1 Lifestyle Drugs Market Segment by Sales Channel
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Lifestyle Drugs Market Size by Sales Channel
4.2.1 Global Lifestyle Drugs Market Size Overview by Sales Channel (2018-2029)
4.2.2 Global Lifestyle Drugs Historic Market Size Review by Sales Channel (2018-2023)
4.2.3 Global Lifestyle Drugs Forecasted Market Size by Sales Channel (2024-2029)
4.3 Key Regions Market Size Segment by Sales Channel
4.3.1 North America Lifestyle Drugs Sales Breakdown by Sales Channel (2018-2023)
4.3.2 Europe Lifestyle Drugs Sales Breakdown by Sales Channel (2018-2023)
4.3.3 Asia-Pacific Lifestyle Drugs Sales Breakdown by Sales Channel (2018-2023)
4.3.4 Latin America Lifestyle Drugs Sales Breakdown by Sales Channel (2018-2023)
4.3.5 Middle East and Africa Lifestyle Drugs Sales Breakdown by Sales Channel (2018-2023)
5 North America Lifestyle Drugs by Country
5.1 North America Lifestyle Drugs Historic Market Size by Country
5.1.1 North America Lifestyle Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Lifestyle Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Lifestyle Drugs Sales in Value by Country (2018-2023)
5.2 North America Lifestyle Drugs Forecasted Market Size by Country
5.2.1 North America Lifestyle Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Lifestyle Drugs Sales in Value by Country (2024-2029)
6 Europe Lifestyle Drugs by Country
6.1 Europe Lifestyle Drugs Historic Market Size by Country
6.1.1 Europe Lifestyle Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Lifestyle Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Lifestyle Drugs Sales in Value by Country (2018-2023)
6.2 Europe Lifestyle Drugs Forecasted Market Size by Country
6.2.1 Europe Lifestyle Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Lifestyle Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Lifestyle Drugs by Region
7.1 Asia-Pacific Lifestyle Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Lifestyle Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Lifestyle Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Lifestyle Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Lifestyle Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Lifestyle Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Lifestyle Drugs Sales in Value by Region (2024-2029)
8 Latin America Lifestyle Drugs by Country
8.1 Latin America Lifestyle Drugs Historic Market Size by Country
8.1.1 Latin America Lifestyle Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Lifestyle Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Lifestyle Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Lifestyle Drugs Forecasted Market Size by Country
8.2.1 Latin America Lifestyle Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Lifestyle Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Lifestyle Drugs by Country
9.1 Middle East and Africa Lifestyle Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Lifestyle Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Lifestyle Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Lifestyle Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Lifestyle Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Lifestyle Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Lifestyle Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Allergan
10.1.1 Allergan Company Information
10.1.2 Allergan Introduction and Business Overview
10.1.3 Allergan Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Allergan Lifestyle Drugs Products Offered
10.1.5 Allergan Recent Development
10.2 Eli Lilly
10.2.1 Eli Lilly Company Information
10.2.2 Eli Lilly Introduction and Business Overview
10.2.3 Eli Lilly Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Eli Lilly Lifestyle Drugs Products Offered
10.2.5 Eli Lilly Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Lifestyle Drugs Products Offered
10.3.5 Pfizer Recent Development
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information
10.4.2 AstraZeneca Introduction and Business Overview
10.4.3 AstraZeneca Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 AstraZeneca Lifestyle Drugs Products Offered
10.4.5 AstraZeneca Recent Development
10.5 Teva
10.5.1 Teva Company Information
10.5.2 Teva Introduction and Business Overview
10.5.3 Teva Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Teva Lifestyle Drugs Products Offered
10.5.5 Teva Recent Development
10.6 Sun Pharmacetuicals
10.6.1 Sun Pharmacetuicals Company Information
10.6.2 Sun Pharmacetuicals Introduction and Business Overview
10.6.3 Sun Pharmacetuicals Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sun Pharmacetuicals Lifestyle Drugs Products Offered
10.6.5 Sun Pharmacetuicals Recent Development
10.7 Merck
10.7.1 Merck Company Information
10.7.2 Merck Introduction and Business Overview
10.7.3 Merck Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Merck Lifestyle Drugs Products Offered
10.7.5 Merck Recent Development
10.8 Forendo Pharma
10.8.1 Forendo Pharma Company Information
10.8.2 Forendo Pharma Introduction and Business Overview
10.8.3 Forendo Pharma Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Forendo Pharma Lifestyle Drugs Products Offered
10.8.5 Forendo Pharma Recent Development
10.9 Avolynt
10.9.1 Avolynt Company Information
10.9.2 Avolynt Introduction and Business Overview
10.9.3 Avolynt Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Avolynt Lifestyle Drugs Products Offered
10.9.5 Avolynt Recent Development
10.10 Alkermes
10.10.1 Alkermes Company Information
10.10.2 Alkermes Introduction and Business Overview
10.10.3 Alkermes Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Alkermes Lifestyle Drugs Products Offered
10.10.5 Alkermes Recent Development
10.11 Dong-A ST
10.11.1 Dong-A ST Company Information
10.11.2 Dong-A ST Introduction and Business Overview
10.11.3 Dong-A ST Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Dong-A ST Lifestyle Drugs Products Offered
10.11.5 Dong-A ST Recent Development
10.12 Dermira
10.12.1 Dermira Company Information
10.12.2 Dermira Introduction and Business Overview
10.12.3 Dermira Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Dermira Lifestyle Drugs Products Offered
10.12.5 Dermira Recent Development
10.13 Avanir Pharmaceuticals
10.13.1 Avanir Pharmaceuticals Company Information
10.13.2 Avanir Pharmaceuticals Introduction and Business Overview
10.13.3 Avanir Pharmaceuticals Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Avanir Pharmaceuticals Lifestyle Drugs Products Offered
10.13.5 Avanir Pharmaceuticals Recent Development
10.14 Menlo Therapeutics
10.14.1 Menlo Therapeutics Company Information
10.14.2 Menlo Therapeutics Introduction and Business Overview
10.14.3 Menlo Therapeutics Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Menlo Therapeutics Lifestyle Drugs Products Offered
10.14.5 Menlo Therapeutics Recent Development
10.15 Galderma
10.15.1 Galderma Company Information
10.15.2 Galderma Introduction and Business Overview
10.15.3 Galderma Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Galderma Lifestyle Drugs Products Offered
10.15.5 Galderma Recent Development
10.16 Cerecor
10.16.1 Cerecor Company Information
10.16.2 Cerecor Introduction and Business Overview
10.16.3 Cerecor Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Cerecor Lifestyle Drugs Products Offered
10.16.5 Cerecor Recent Development
10.17 Corcept Therapeutics
10.17.1 Corcept Therapeutics Company Information
10.17.2 Corcept Therapeutics Introduction and Business Overview
10.17.3 Corcept Therapeutics Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Corcept Therapeutics Lifestyle Drugs Products Offered
10.17.5 Corcept Therapeutics Recent Development
10.18 Anterios
10.18.1 Anterios Company Information
10.18.2 Anterios Introduction and Business Overview
10.18.3 Anterios Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Anterios Lifestyle Drugs Products Offered
10.18.5 Anterios Recent Development
10.19 Euthymics Bioscience
10.19.1 Euthymics Bioscience Company Information
10.19.2 Euthymics Bioscience Introduction and Business Overview
10.19.3 Euthymics Bioscience Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Euthymics Bioscience Lifestyle Drugs Products Offered
10.19.5 Euthymics Bioscience Recent Development
10.20 Cosmo Pharmaceuticals
10.20.1 Cosmo Pharmaceuticals Company Information
10.20.2 Cosmo Pharmaceuticals Introduction and Business Overview
10.20.3 Cosmo Pharmaceuticals Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Cosmo Pharmaceuticals Lifestyle Drugs Products Offered
10.20.5 Cosmo Pharmaceuticals Recent Development
10.21 AndroScience
10.21.1 AndroScience Company Information
10.21.2 AndroScience Introduction and Business Overview
10.21.3 AndroScience Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.21.4 AndroScience Lifestyle Drugs Products Offered
10.21.5 AndroScience Recent Development
10.22 Acerus Pharmaceuticals
10.22.1 Acerus Pharmaceuticals Company Information
10.22.2 Acerus Pharmaceuticals Introduction and Business Overview
10.22.3 Acerus Pharmaceuticals Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.22.4 Acerus Pharmaceuticals Lifestyle Drugs Products Offered
10.22.5 Acerus Pharmaceuticals Recent Development
10.23 Celtaxsys
10.23.1 Celtaxsys Company Information
10.23.2 Celtaxsys Introduction and Business Overview
10.23.3 Celtaxsys Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.23.4 Celtaxsys Lifestyle Drugs Products Offered
10.23.5 Celtaxsys Recent Development
10.24 Futura Medical Developments
10.24.1 Futura Medical Developments Company Information
10.24.2 Futura Medical Developments Introduction and Business Overview
10.24.3 Futura Medical Developments Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.24.4 Futura Medical Developments Lifestyle Drugs Products Offered
10.24.5 Futura Medical Developments Recent Development
10.25 Follicum
10.25.1 Follicum Company Information
10.25.2 Follicum Introduction and Business Overview
10.25.3 Follicum Lifestyle Drugs Sales, Revenue and Gross Margin (2018-2023)
10.25.4 Follicum Lifestyle Drugs Products Offered
10.25.5 Follicum Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Lifestyle Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Lifestyle Drugs Industrial Chain Analysis
11.4 Lifestyle Drugs Market Dynamics
11.4.1 Lifestyle Drugs Industry Trends
11.4.2 Lifestyle Drugs Market Drivers
11.4.3 Lifestyle Drugs Market Challenges
11.4.4 Lifestyle Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Lifestyle Drugs Distributors
12.3 Lifestyle Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
